Difference between revisions of "PMID:20440275"
(New PMID: Page!) |
(Adding categories) |
||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
+ | {{RightTOC}} | ||
+ | <!--box uid=2ccfb3c7bf1208312f02a69e64bfd9e0.190.N4d09121059127--> | ||
+ | <!-- | ||
+ | ****************************************************************************************** | ||
+ | * | ||
+ | * ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | ||
+ | * | ||
+ | ****************************************************************************************** --> | ||
+ | {| id="N4d09121059127" class=" tableEdit PMID_info_table" | ||
+ | |||
+ | |- | ||
+ | !align=left |Citation | ||
+ | || | ||
+ | '''Kohanski, MA, Dwyer, DJ and Collins, JJ''' (2010) How antibiotics kill bacteria: from targets to networks.''Nat. Rev. Microbiol.'' '''8''':423-35 | ||
+ | |- | ||
+ | !align=left |Abstract | ||
+ | || | ||
+ | Antibiotic drug-target interactions, and their respective direct effects, are generally well characterized. By contrast, the bacterial responses to antibiotic drug treatments that contribute to cell death are not as well understood and have proven to be complex as they involve many genetic and biochemical pathways. In this Review, we discuss the multilayered effects of drug-target interactions, including the essential cellular processes that are inhibited by bactericidal antibiotics and the associated cellular response mechanisms that contribute to killing. We also discuss new insights into these mechanisms that have been revealed through the study of biological networks, and describe how these insights, together with related developments in synthetic biology, could be exploited to create new antibacterial therapies. | ||
+ | |- | ||
+ | !align=left |Links | ||
+ | || | ||
+ | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20440275 PubMed] | ||
+ | Online version:[http://dx.doi.org/10.1038/nrmicro2333 10.1038/nrmicro2333] | ||
+ | |- | ||
+ | !align=left |Keywords | ||
+ | || | ||
+ | Anti-Bacterial Agents; Bacteria; Cell Wall; DNA Replication; Drug Discovery; Nucleic Acid Synthesis Inhibitors; Quinolones; RNA; Rifamycins | ||
+ | |||
+ | |- class="tableEdit_footer" | ||
+ | |<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=2ccfb3c7bf1208312f02a69e64bfd9e0.190.N4d09121059127&page=190&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> || | ||
+ | |} | ||
+ | <!--box uid=2ccfb3c7bf1208312f02a69e64bfd9e0.190.N4d09121059127--> | ||
+ | |||
+ | ==Main Points of the Paper == | ||
+ | {{LitSignificance}} | ||
+ | |||
+ | This review on antibiotic mechanisms argues that in many cases cell killing by antibiotics with diverse targets is due to a common indirect mechanism involving induction of oxidative stress leading to hydroxyl radical production. See Figure 2. | ||
+ | |||
+ | == Materials and Methods Used == | ||
+ | {{LitMaterials}} | ||
+ | |||
+ | ==Phenotype Annotations== | ||
+ | {{AnnotationTableHelp}} | ||
+ | <protect><!--box uid=2ccfb3c7bf1208312f02a69e64bfd9e0.190.I4d09121068b61--> | ||
+ | <!-- | ||
+ | ****************************************************************************************** | ||
+ | * | ||
+ | * ** PLEASE DON'T EDIT THIS TABLE DIRECTLY. Use the edit table link under the table. ** | ||
+ | * | ||
+ | ****************************************************************************************** --> | ||
+ | {| id="I4d09121068b61" class=" tableEdit PMID_Phenotype_table" | ||
+ | |- | ||
+ | !|Species!!Taxon ID!!Strain!!Gene (if known)!!OMP!!Phenotype!!Details!!Evidence!!Notes | ||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Inhibition of DNA replication | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | topoisomerase-catalysed DNA strand breakage | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Inhibition of RNA synthesis | ||
+ | | | ||
+ | |||
+ | | | ||
+ | * rifampicin | ||
+ | * streptolydigin | ||
+ | * amanitin (eukaryotes) | ||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Inhibition of cell wall synthesis | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Inhibition of cell wall synthesis resulting in lysis | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Inhibition of protein synthesis | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Increased protein mistranslation | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Induction of hydroxyl radical production | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | |- | ||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | |||
+ | | | ||
+ | Sensitivity to | ||
+ | | | ||
+ | Loss of membrane potential | ||
+ | | | ||
+ | |||
+ | | | ||
+ | * uncouplers | ||
+ | * pore-formers | ||
+ | |||
+ | |- class="tableEdit_footer" | ||
+ | |<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=2ccfb3c7bf1208312f02a69e64bfd9e0.190.I4d09121068b61&page=190&pagename={{FULLPAGENAMEE}}&type=0&template=PMID_Phenotype_table edit table]</span> || || || || || || || || | ||
+ | |} | ||
+ | <!--box uid=2ccfb3c7bf1208312f02a69e64bfd9e0.190.I4d09121068b61--></protect> | ||
+ | |||
+ | ==Notes== | ||
+ | |||
+ | ==References== | ||
+ | {{RefHelp}} | ||
+ | <references/> | ||
+ | |||
+ | [[Category:Publication]] | ||
+ | [[Category:To Be Converted]] |
Latest revision as of 12:09, 22 June 2011
Citation |
Kohanski, MA, Dwyer, DJ and Collins, JJ (2010) How antibiotics kill bacteria: from targets to networks.Nat. Rev. Microbiol. 8:423-35 |
---|---|
Abstract |
Antibiotic drug-target interactions, and their respective direct effects, are generally well characterized. By contrast, the bacterial responses to antibiotic drug treatments that contribute to cell death are not as well understood and have proven to be complex as they involve many genetic and biochemical pathways. In this Review, we discuss the multilayered effects of drug-target interactions, including the essential cellular processes that are inhibited by bactericidal antibiotics and the associated cellular response mechanisms that contribute to killing. We also discuss new insights into these mechanisms that have been revealed through the study of biological networks, and describe how these insights, together with related developments in synthetic biology, could be exploited to create new antibacterial therapies. |
Links |
PubMed Online version:10.1038/nrmicro2333 |
Keywords |
Anti-Bacterial Agents; Bacteria; Cell Wall; DNA Replication; Drug Discovery; Nucleic Acid Synthesis Inhibitors; Quinolones; RNA; Rifamycins |
edit table |
Main Points of the Paper
Please summarize the main points of the paper.
This review on antibiotic mechanisms argues that in many cases cell killing by antibiotics with diverse targets is due to a common indirect mechanism involving induction of oxidative stress leading to hydroxyl radical production. See Figure 2.
Materials and Methods Used
Please list the materials and methods used in this paper (strains, plasmids, antibodies, etc).
Phenotype Annotations
See Help:AnnotationTable for details on how to edit this table.
<protect>
Species | Taxon ID | Strain | Gene (if known) | OMP | Phenotype | Details | Evidence | Notes |
---|---|---|---|---|---|---|---|---|
Sensitivity to |
Inhibition of DNA replication |
|||||||
Sensitivity to |
topoisomerase-catalysed DNA strand breakage |
|||||||
Sensitivity to |
Inhibition of RNA synthesis |
| ||||||
Sensitivity to |
Inhibition of cell wall synthesis |
|||||||
Sensitivity to |
Inhibition of cell wall synthesis resulting in lysis |
|||||||
Sensitivity to |
Inhibition of protein synthesis |
|||||||
Sensitivity to |
Increased protein mistranslation |
|||||||
Sensitivity to |
Induction of hydroxyl radical production |
|||||||
Sensitivity to |
Loss of membrane potential |
| ||||||
edit table |
</protect>
Notes
References
See Help:References for how to manage references in omp dev.